Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,363 public trials 405 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Completed

Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma

NCT00019682

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Kaiser Permanente Medical Center Riverside, California, United States
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 19 locations
View Trial Details
Completed

A Pharmacokinetics (PK) Study of the Effects Rabeprazole and Rifampin on Dabrafenib in Subjects With BRAF V600 Mutation Positive Tumors

NCT01954043

Conditions
Cancer, Melanoma, Neoplasms, +10 more
Locations
  • GSK Investigational Site Goodyear, Arizona, United States
  • GSK Investigational Site Dallas, Texas, United States
  • GSK Investigational Site Tacoma, Washington, United States
  • GSK Investigational Site Heidelberg, Victoria, Australia
View Trial Details
Completed

Study of Dabrafenib +/- Trametinib in Combination With Ipilimumab for V600E/K Mutation Positive Metastatic or Unresectable Melanoma

NCT01767454

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site St Louis, Missouri, United States
View Trial Details
Completed

Open-label Study to Investigate the Safety, PK, and Pharmacodynamics of GSK1120212 in Subjects With Solid Tumors or Lymphoma

NCT00687622

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Fort Myers, Florida, United States
  • GSK Investigational Site Ocoee, Florida, United States
View Trial Details
Completed

A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma

NCT01227889

Conditions
Cancer, Melanoma, Neoplasms, +10 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site La Jolla, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 94 locations
View Trial Details

Related conditions